BlackRock Group Ltd’s Top 3 Healthcare Stocks: JNJ, PFE, MRK

Wall St. Watchdog reveals information regarding BlackRock Group Ltd’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 216 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $9.727 billion.

  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, BlackRock Group Ltd reported holding 20,386,607 shares with a market value of $1,356,117,029. This comprised 1.03% of the total portfolio. On 09/30/2011, BlackRock Group Ltd reported holding 22,853,227 shares with a market value of $1,455,521,996. This comprised 1.34% of the total portfolio. The net change in shares for this position over the two quarters is 2,466,620. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, BlackRock Group Ltd reported holding 63,320,533 shares with a market value of $1,304,403,004. This comprised 0.99% of the total portfolio. On 09/30/2011, BlackRock Group Ltd reported holding 66,044,934 shares with a market value of $1,167,674,453. This comprised 1.07% of the total portfolio. The net change in shares for this position over the two quarters is 2,724,401. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, BlackRock Group Ltd reported holding 25,542,565 shares with a market value of $901,397,142. This comprised 0.68% of the total portfolio. On 09/30/2011, BlackRock Group Ltd reported holding 25,387,169 shares with a market value of $830,160,446. This comprised 0.76% of the total portfolio. The net change in shares for this position over the two quarters is -155,396. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, BlackRock Group Ltd reported holding 9,823,893 shares with a market value of $516,933,239. This comprised 0.39% of the total portfolio. On 09/30/2011, BlackRock Group Ltd reported holding 9,983,127 shares with a market value of $510,537,109. This comprised 0.47% of the total portfolio. The net change in shares for this position over the two quarters is 159,234. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Bristol-myers Squibb Company (NYSE:BMY): On 06/30/2011, BlackRock Group Ltd reported holding 17,059,101 shares with a market value of $494,031,549. This comprised 0.37% of the total portfolio. On 09/30/2011, BlackRock Group Ltd reported holding 13,845,406 shares with a market value of $434,468,829. This comprised 0.4% of the total portfolio. The net change in shares for this position over the two quarters is -3,213,695. About Company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Amgen Inc. (NASDAQ:AMGN): On 06/30/2011, BlackRock Group Ltd reported holding 7,841,123 shares with a market value of $457,529,515. This comprised 0.35% of the total portfolio. On 09/30/2011, BlackRock Group Ltd reported holding 7,321,391 shares with a market value of $402,383,643. This comprised 0.37% of the total portfolio. The net change in shares for this position over the two quarters is -519,732. About Company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, BlackRock Group Ltd reported holding 8,213,648 shares with a market value of $423,659,979. This comprised 0.32% of the total portfolio. On 09/30/2011, BlackRock Group Ltd reported holding 7,733,419 shares with a market value of $356,665,276. This comprised 0.33% of the total portfolio. The net change in shares for this position over the two quarters is -480,229. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Eli Lilly & Co. (NYSE:LLY): On 06/30/2011, BlackRock Group Ltd reported holding 8,690,617 shares with a market value of $326,158,845. This comprised 0.25% of the total portfolio. On 09/30/2011, BlackRock Group Ltd reported holding 8,064,303 shares with a market value of $298,137,292. This comprised 0.27% of the total portfolio. The net change in shares for this position over the two quarters is -626,314. About Company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
  • Medtronic Inc. (NYSE:MDT): On 06/30/2011, BlackRock Group Ltd reported holding 8,324,608 shares with a market value of $320,747,136. This comprised 0.24% of the total portfolio. On 09/30/2011, BlackRock Group Ltd reported holding 8,322,360 shares with a market value of $276,635,260. This comprised 0.25% of the total portfolio. The net change in shares for this position over the two quarters is -2,248. About Company: Medtronic, Inc. develops therapeutic and diagnostic medical products. The Company’s principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic’s products are sold worldwide.
  • Baxter International Inc. (NYSE:BAX): On 06/30/2011, BlackRock Group Ltd reported holding 4,873,001 shares with a market value of $290,869,423. This comprised 0.22% of the total portfolio. On 09/30/2011, BlackRock Group Ltd reported holding 4,778,022 shares with a market value of $268,238,152. This comprised 0.25% of the total portfolio. The net change in shares for this position over the two quarters is -94,979. About Company: Baxter International Inc. develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and research laboratories.

(Note: Data regarding BlackRock Group Ltd’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>